Next Article in Journal
Novel Methodology for Pharmaceutical Expenditure Forecast
Previous Article in Journal
Is the Gap Between Micro- and Macroeconomic Assessments in Health Care Well Understood? The Case of Vaccination and Potential Remedies
 
 
Journal of Market Access & Health Policy (JMAHP) is published by MDPI from Volume 12 Issue 1 (2024). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Taylor & Francis.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Health Technology Assessment in Middle-Income Countries: Recommendations for a Balanced Assessment System

Corvinus University of Budapest, Institute of Management, H-1093 Fővámtér 8, Budapest, Hungary
J. Mark. Access Health Policy 2014, 2(1), 23181; https://doi.org/10.3402/jmahp.v2.23181
Submission received: 27 October 2013 / Revised: 6 January 2014 / Accepted: 29 January 2014 / Published: 11 March 2014

Abstract

Because of significant differences in institutional contexts, health technology assessment (HTA) systems that are in place in core pharmaceutical markets may not be suitable, fully or in part, for middle-income countries (MICs) and for other noncore markets. Particular challenges may arise when systems based on the economic evaluation paradigm are conceptualized and implemented in MICs, sometimes with an insufficient level of awareness of the local institutional factors that influence pricing and reimbursement decision making. Focusing on pharmaceuticals, this article investigates possible development directions for HTA systems in MICs and noncore markets bearing similar institutional characteristics, and it provides recommendations for a balanced assessment system (BAS). For this, the main paradigms of HTA have also been reviewed briefly and factors influencing HTA and pricing and reimbursement decisions in MICs and in similar noncore countries have been summarized. The proposed BAS framework takes into account available resources and capabilities and is supposed to facilitate access to new pharmaceuticals while ensuring the transparency of decision-making processes and the stability of the pharmaceutical budget.
Keywords: health technology assessment (HTA); middle-income countries (MIC); balanced assessment; multi-criteria decision analysis (MCDA); pharmaceutical assessment; reimbursement decisions health technology assessment (HTA); middle-income countries (MIC); balanced assessment; multi-criteria decision analysis (MCDA); pharmaceutical assessment; reimbursement decisions

Share and Cite

MDPI and ACS Style

Dankó, D. Health Technology Assessment in Middle-Income Countries: Recommendations for a Balanced Assessment System. J. Mark. Access Health Policy 2014, 2, 23181. https://doi.org/10.3402/jmahp.v2.23181

AMA Style

Dankó D. Health Technology Assessment in Middle-Income Countries: Recommendations for a Balanced Assessment System. Journal of Market Access & Health Policy. 2014; 2(1):23181. https://doi.org/10.3402/jmahp.v2.23181

Chicago/Turabian Style

Dankó, Dávid. 2014. "Health Technology Assessment in Middle-Income Countries: Recommendations for a Balanced Assessment System" Journal of Market Access & Health Policy 2, no. 1: 23181. https://doi.org/10.3402/jmahp.v2.23181

APA Style

Dankó, D. (2014). Health Technology Assessment in Middle-Income Countries: Recommendations for a Balanced Assessment System. Journal of Market Access & Health Policy, 2(1), 23181. https://doi.org/10.3402/jmahp.v2.23181

Article Metrics

Back to TopTop